Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Diet, Lifestyle, Systemic Medication and Genetics: Can the Risk for AMD be Modulated?

Authors not listed

Association for Innovation and Biomedical Research on Light and Image · 2023

Abstract

The goal of this Cross-sectional, interventional study is to learn about whether different risk factors, as Mediterranean diet, lifestyle and concomitant medication can modulate the risk imprinted by genetics in Age-related macular degeneration (AMD). The main question it aims to answer is: How the genetic risk interacts with environmental and lifestyle factors, especially Mediterranean diet and chronic medication, in order to assess how this interplay protects or presents higher risk for the establishment or the progression of AMD. Participants: Vital Signs will be measured; Medical History, Demographics, Nutritional/lifestyle habits and Family History of AMD will be recorded; Ophthalmological Examination will be performed Genetic analysis will be performed.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-08 MST

Cite this

APA
Anonymous. (2023). Diet, Lifestyle, Systemic Medication and Genetics: Can the Risk for AMD be Modulated?. <em>Association for Innovation and Biomedical Research on Light and Image</em>. https://clinicaltrials.gov/study/NCT05735730
Vancouver
Anonymous. Diet, Lifestyle, Systemic Medication and Genetics: Can the Risk for AMD be Modulated?. Association for Innovation and Biomedical Research on Light and Image. 2023.
BibTeX
@misc{anon2023DietLi, title = {Diet, Lifestyle, Systemic Medication and Genetics: Can the Risk for AMD be Modulated?}, author = {Anonymous}, journal = {Association for Innovation and Biomedical Research on Light and Image}, year = {2023}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings